2015
New onset executive function difficulties at menopause: a possible role for lisdexamfetamine
Epperson CN, Shanmugan S, Kim DR, Mathews S, Czarkowski KA, Bradley J, Appleby DH, Iannelli C, Sammel MD, Brown TE. New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacology 2015, 232: 3091-3100. PMID: 26063677, PMCID: PMC4631394, DOI: 10.1007/s00213-015-3953-7.Peer-Reviewed Original ResearchConceptsBrown Attention-Deficit Disorder ScaleExecutive function difficultiesExecutive functionAttention Deficit Disorder ScaleLDX treatmentObjective cognitive functionMemory taskVerbal memoryVerbal recallCognitive measuresParagraph recallLifetime ADHDCognitive functionCognitive declineDisorder ScaleSubjective measuresMenopausal womenSubscale scoresLisdexamfetamineObjective measuresRecallEarly postmenopausal womenSystolic blood pressureCross-over studyHealthy menopausal women
2011
Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women
Epperson CN, Pittman B, Czarkowski KA, Bradley J, Quinlan DM, Brown TE. Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women. Menopause The Journal Of The North American Menopause Society 2011, 18: 542-548. PMID: 21293309, PMCID: PMC4076798, DOI: 10.1097/gme.0b013e3181fcafd6.Peer-Reviewed Original ResearchConceptsAttention-deficit/hyperactivity disorderBrown Attention-Deficit Disorder ScaleCognitive difficultiesHistory of ADHDBehavioral assessmentSubjective cognitive difficultiesAttention Deficit Disorder ScaleAttention/concentrationConcentration/attentionShort-term memorySimilar cognitive impairmentsCluster scoresATX treatmentExecutive functionSubjective attentionMemory difficultiesHyperactivity disorderNeuropsychological testsNeuropsychological testingCognitive symptomsDisorder ScaleSubjective difficultyAtomoxetineCognitive impairmentMemory